Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer.

Authors:
Jain S; Nadeem N; Ulfenborg B; Mäkelä M; Ruma SA and 7 more

Journal:
Int J Cancer

Publication Year: 2022

DOI:
10.1002/ijc.34111

PMCID:
PMC9546485

PMID:
35531590

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Int J Cancer

Abbreviation: Int J Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Chronic acidosis rewires cancer cell metabolism through PPARα signaling.
Rolver MG; Holland LKK; Ponniah M and 11 more (2023) - Transparency Score: 4/6
A defect of amphiregulin release predicted longer survival independently of YAP expression in patie…
Maille E; Levallet J; Dubois F and 17 more (2022) - Transparency Score: 3/6
Agricultural activities and risk of central nervous system tumors among French farm managers: Resul…
Petit P; Gandon G; Chabardès S and 1 more (2022) - Transparency Score: 3/6
A hybrid design for dose-finding oncology clinical trials.
Liao JJZ; Zhou F; Zhou H and 3 more (2022) - Transparency Score: 3/6
A nationwide longitudinal study on risk factors for progression of anal intraepithelial neoplasia g…
Faber MT; Frederiksen K; Palefsky JM and 1 more (2022) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST Kim Pettersson and Kamlesh Gidwani are co‐applicants on a patent application on the use of CA125‐MGL for ovarian cancer. The other authors declare no conflict of interest."

Evidence found in paper:

"Funding information ALF‐VGR Region, Sweden, Grant/Award Numbers: ALFGBG‐721051, ALFGBG‐932583; Jane ja Aatos Erkon Säätiö; Nordic Cancer Union, Denmark, Grant/Award Number: 194914; Swedish Cancer Foundation, Grant/Award Number: CAN‐2018/834"

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025